MENUNews Archive
Date: 09/23/2014
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, 800-865-1125
Date: 09/04/2014
Gene therapy developed by Dr. Maria Castro and Dr. Pedro Lowenstein will now get the first test in human patients. The experimental approach, based on their research while at the University of Michigan, delivers two different genes directly into the brains of patients following the operation to remove the bulk of their tumors.
Date: 09/04/2014
Researchers at the University of Michigan School of Nursing and Rogel Cancer Center have received a $2.3 million grant to study oncology nurses’ exposure to hazardous drugs, including identifying ways to reduce exposure. According to Christopher Friese, Ph.D., R.N., AOCN, FAAN, University of Michigan School of Nursing assistant professor and member of U-M’s Rogel Cancer Center and Institute for Healthcare Policy and Innovation, there are significant acute and long-term side effects from hazardous drug exposures in oncology settings, but not enough evidence-based, risk-reduction efforts to protect health care workers.
Date: 08/12/2014
The content on this page is out of date. To learn about fundraising events, please visit the Community Events page.
Date: 08/07/2014
Like a stealth fighter jet, the coating means the cells evade detection by the early-warning immune system that should detect and kill them. The stealth approach lets the tumors hide until it’s too late for the body to defeat them.
Date: 08/07/2014
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to a new study.
Date: 08/06/2014
The content on this page is out of date. To learn about fundraising events, please visit the Community Events page.
Date: 08/04/2014
University of Michigan researchers have found that a particular protein -- TRIP13 -- encourages those cancer cells to repair themselves. And they have identified an existing chemical that blocks this mechanism for cell repair. And they have identified an existing chemical that blocks this mechanism for cell repair. "This is a very significant advance, because identifying the function of the protein that fuels the repair of cancer cells and having an existing chemical that blocks the process, could speed the process of moving to clinical trials," said principal investigator Nisha D'Silva, U-M professor of dentistry and associate professor of pathology.
Date: 07/16/2014
The number of younger men diagnosed with prostate cancer has increased nearly 6-fold in the last 20 years, and the disease is more likely to be aggressive in these younger men, according to a new analysis.
Date: 06/25/2014
African-Americans with colon cancer are half as likely as Caucasian patients to have a type of colon cancer that is linked to better outcomes. The finding may provide insight into why African-Americans are more likely to die of colon cancer than Caucasians with the same stage of disease.